Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/20564116

Cancer 2010 Sep 1 116 17 4114-21

Download in:

View as

General Info

PMID
20564116